FierceMedicalDevices sports a new look

As you may have noticed, we've redesigned the email newsletter format for FierceMedicalDevices to look more like sister pubs FiercePharma and FierceBiotech. We decided to do this to enhance the reader's experience. We hope you like the change.

With the new layout, our mission remains the same: bringing you, the reader, the best device coverage possible. We hope you have a pleasant weekend and look forward to seeing you again Monday with breaking device news. In the meantime, please check out our Top 10 Medical Device R&D Budgets to see where your favorite device company placed. -- Liz Hollis (email | Twitter)

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.